ZymoGenetics
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, ZymoGenetics sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
ZymoGenetics: 9 sponsored US clinical trials, none currently recruiting.
ZymoGenetics sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 9 completed. 4 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hepatitis C, Chronic, with 1 trials.
Top-decile sponsor footprint
ZymoGenetics ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants
NCT00859547
Immunogenicity and Safety Study of rThrombin in Surgical Hemostasis
NCT00813904
Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection
NCT00565539
Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis
NCT00491608
Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma
NCT00389285
Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting
NCT00371215
Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma
NCT00347971
Study of Recombinant Human Thrombin for Bleeding During Surgery
NCT00245336
Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer
NCT00095108
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
How the ZymoGenetics archive is shaped
9 indexed studies, none listed as recruiting (0% open); 9 completed (100%).
Phase mix: 4 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Hepatitis C, Chronic (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
ZymoGenetics: archived-pipeline peers nationwide
Peers matched on 9 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
ZymoGenetics sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 archived trials
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this ZymoGenetics page
9 registered trials is a research-attention snapshot, not an endorsement of ZymoGenetics or any single study.
- None of ZymoGenetics's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Hepatitis C, Chronic is the condition ZymoGenetics studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hepatitis C, Chronic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
ZymoGenetics pipeline card: 9 registered trials from official public datasets.Report a data error.